>
Dechra Pharmaceuticals collapsed after the veterinary drug maker issued a profit warning due to “unpredictable” trading.
The FTSE 250 company, which makes medicines for pet treatment, said its annual profit would be at the lower end of analyst estimates at around £188 million.
The warning came after US wholesalers reduced their inventory levels by using existing items instead of purchasing new ones.
Earnings warning: Dechra Pharmaceuticals, which makes medicines to treat pets, said annual profits would be at the lower end of analyst estimates of around £188 million
Dechra said the first half of the financial year – the six months to the end of December – was “robust” with sales up 13.5 per cent to £377.4 million. But profits fell 3.8 percent to £90.3 million. Shares fell 9.2 percent, or 286 pence, to 2,818 pence.
Analysts from Liberum expressed confidence, saying they see “the outlook for pet spending improving.”
The FTSE 100 gained 0.7 percent, or 56.45 points, to 7935.11 and the FTSE 250 gained 1 percent, or 189.57 points, to 19886.1.
Bunzl started the week well after it agreed to acquire German company Arbeitsschutz-Express and sealed the acquisition of Capital Paper in Canada.
The blue-chip company, which supplies products such as paper napkins, disposable coffee cups and latex gloves to private companies and the public sector, bought 12 companies in 2022 for £322 million.
Turnover rose 17 percent to £12 billion last year, while profits rose 11.6 percent to £634.6 million.
Bunzl increased its dividend for the 30th year in a row.
It also reiterated its forecasts for 2023, with sales expected to be slightly higher than in 2022. Shares were up 2.5 percent, or 75p, to 3088p.
Investors in Rolls-Royce will have much to cheer on what has been a remarkable start to 2023.
Shares are up more than 50 percent year-to-date as the jet engine maker continues to garner the city’s attention.
Jefferies raised the target price from 125 pence to 170 pence, while Bank of America upgraded them to “buy.” Shares added 6.6 percent or 8.96p to 145p.
The boss of Senior, which counts Rolls-Royce, Airbus and Boeing among its customers, said the “airspace recovery is in full swing as a result of people wanting to fly again.”
The upbeat outlook came after the aerospace and defense group reported a £20.1m profit for 2022, following a loss of £1.9m a year earlier.
Annual profit surpassed the £16.2 million to £18 million analysts had expected. Shares rose 6.8 percent, or 11 pence, to 173.4 pence.
There was also good news for DX shareholders after the delivery and logistics company said it would pay a dividend for the first time in six years.
Investors will pocket an interim dividend of 0.5 pence per share after things improve. Sales were up 15 per cent to £231.3 million for six months to 31 December, while profits were up 176 per cent to £9.1 million. Shares rose 2.7 percent, or 0.75 pence, to 29 pence.
Trainline, meanwhile, rose 5.2 percent, or 12.8 pence, to 258.8 pence after Deutsche Bank Research upgraded the card seller’s rating from “buy” to “hold.”
But Quilter fell 2.8 percent, or 2.7 pence, to 92.92 pence after Citigroup downgraded the asset manager from “neutral” to “sell” and cut its target price from 100 pence to 75 pence.
A company backed by David Beckham signed a contract with Samsung just a month after it launched its new studio.
Guild Esports, which manages teams that compete in video game tournaments, said its studio has added a new revenue stream.
The former England and Manchester United captain owns 24.57 million shares with his 4.74 percent stake in Guild.
Boss Jasmine Skee said, “Creating new revenue streams and generating value for investors are the company’s key goals for 2023.”
Guild shares rose 8.1 percent, or 0.08 pence, to 1 pence.
Some links in this article may be affiliate links. If you click on it, we may earn a small commission. That helps us fund This Is Money and use it for free. We do not write articles to promote products. We do not allow any commercial relationship to compromise our editorial independence.